AndroGel Lawsuit Information
The testosterone replacement therapy litigation is still in its early stages, but it is ultimately expected that thousands of TRT lawsuits will be filed in state and federal courts across the country, on behalf of men who suffered heart attacks, strokes and other complications from low-T treatments. All of the testosterone therapy lawsuits involve similar allegations that the drug manufacturing companies failed to provide adequate warnings to consumers and the medical community about the potential for AndroGel and other low-T products to cause heart attack, stroke and other side effects in users. As part of the coordinated discovery in the testosterone therapy MDL, a small group of AndroGel injury lawsuits are being prepared for early trial dates in 2016.
Compensation for alleged AndroGel side effects may be available through a testosterone therapy lawsuit, and more than a dozen product liability lawsuits have already been brought against the makers of testosterone products like AndroGel and Testim, alleging heart attacks, strokes and other injuries from the low-T treatments. In June 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) centralized all federal testosterone therapy lawsuits before one judge for coordinated pretrial proceedings as part of an MDL.